Tags Vaccine

vaccine

Study: Robust T-Cell Immunity Found in Those with Asymptomatic, Mild COVID-19

Marcus Buggert, PhD, Assistant Professor, Department of Medicine Huddinge, Karolinska Institute, Sweden.  Dr. Buggert is a viral immunologist that has focused his career on T cells in the context of HIV infection. During this teleconference, Dr. Buggert describes the most recent data on T cell immunity in COVID-19 patients. Additionally, he provides an update on the "knowns" and "unknowns"...

Expert Insights into National COVID-19 Vaccine Development

Peter J. Hotez, MD, PhD, Dean, School of Tropical Medicine, Baylor College of Medicine; Professor of Pediatrics and Molecular Virology & Microbiology, Baylor College of Medicine; Adjunct Professor, UT School of Public Health; Chair, Tropical Pediatrics, Texas Children’s Hospital; and Co-Director, Texas Children’s Center for Vaccine Development (CVD). COVID-19 vaccine development, manufacturing, and distribution is a complex and multi-layered...

COVID-19 and Health Disparities: Addressing Health Disparities Now, Preparing for Vaccination and Beyond at CCHMC

Rob Kahn, MD, MPH, Physician Lead, Community and Population Health, and Andy Beck, MD, MPH, Associate Professor & Attending Pediatrician, Cincinnati Children's Hospital Medical Center.  The COVID-19 pandemic shines a light on disparities by race, ethnicity and poverty that have long been present across a range of health outcomes. To respond to COVID-19, from surge to vaccine, strategies that promote health equity must be identified...

Current and Future Ethical Challenges of Vaccination for COVID-19

Arthur Caplan, PhD, Drs. William F. and Virginia Connolly Mitty Professor and Founding Head of the Division of Medical Ethics, NYU School of Medicine.  Many believe that the only solution to the COVID-19 plague is to find a vaccine.  Efforts to speed that discovery involve unprecedented investments of money, involvement by hundreds of research teams and novel collaborations.  But...

The COVID-19 Pandemic and Our Nation’s Hospitals: What’s Next?

Paul Keckley, PhD, Managing Editor, The Keckley Report; and Michael T. Osterholm, PhD, MPH, Director, Center for Infectious Disease Research and Policy (CIDRAP), the University of Minnesota.  Hospitals across the country have responded courageously and admirably as the nation’s public health servants to address and manage the international COVID-19 pandemic. Capacity management models have been critical to guide shelter-at-home policies;...

Beaumont Health’s Rapid Response and Solutions during the COVID-19 Pandemic

Marjorie Mathews, VP Healthcare Applications, and Joyce Oh, VP Business Systems / Enterprise Data Management / PMO, Beaumont Health. Beaumont Health has treated the most patients with COVID-19 in Michigan, which currently has the third highest deaths from COVID-19 in the country. Beaumont’s Research Institute has launched the nation’s largest serological testing study to date in an effort to answer...